Cargando…

Multidrug-resistant Citrobacter freundii ST139 co-producing NDM-1 and CMY-152 from China

The emergence of carbapenemase-producing Citrobacter freundii poses a significant threat to public health worldwide. Here, we reported a C. freundii strain CWH001 which was resistant to all tested antimicrobials except tetracycline. Whole genome sequencing and analysis were performed. The strain, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lang, Li, Peihan, Liang, Beibei, Hu, Xiaofeng, Li, Jinhui, Xie, Jing, Yang, Chaojie, Hao, Rongzhang, Wang, Ligui, Jia, Leili, Li, Peng, Qiu, Shaofu, Song, Hongbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045649/
https://www.ncbi.nlm.nih.gov/pubmed/30006537
http://dx.doi.org/10.1038/s41598-018-28879-9
Descripción
Sumario:The emergence of carbapenemase-producing Citrobacter freundii poses a significant threat to public health worldwide. Here, we reported a C. freundii strain CWH001 which was resistant to all tested antimicrobials except tetracycline. Whole genome sequencing and analysis were performed. The strain, which belonged to a new sequence type ST139, showed close relationship with other foreign C. freundii strains through phylogenetic analysis. A novel variant of the intrinsic bla(CMY) gene located on the chromosome was identified and designated as bla(CMY-152). Coexistence of bla(NDM-1) with qnrS1 was found on a conjugative IncN plasmid, which had a backbone appearing in various plasmids. Other class A ESBL genes (bla(VEB-3) and bla(TEM-1)) were also detected on two different novel plasmids. The emergence of multidrug-resistant C. freundii is of major concern, causing great challenges to the treatment of clinical infections. Great efforts need to be taken for the specific surveillance of this opportunistic pathogen.